PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2026Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine0 citations

Deprescribing in Older Populations: A Comprehensive Review of Evidence, Strategies, and Future Directions

View Full Paper
SAShoaib AlamMOMuhammad OsamaCWCalvin R. Wei

Key Points

  • This review aims to provide a thorough understanding of deprescribing in older adults, including its evidence, benefits, and strategies for implementation.
  • Conducted a narrative review using multiple databases such as Embase, Google Scholar, PubMed, and Scopus.
  • Included studies on deprescribing interventions, systematic reviews, and articles on implementation barriers.
  • Hand-searched references for additional relevant studies.
  • Deprescribing interventions significantly reduce adverse drug reactions and healthcare utilization.
  • Success rates for deprescribing range from 67.4% to 96.9% in various clinical settings.
  • Negative effects occur in approximately 26% of cases, including withdrawal symptoms and disease relapse.
  • Key facilitators include patient-centred approaches and multidisciplinary collaboration, while barriers involve clinician reluctance and time constraints.
  • Emerging artificial intelligence technologies may enhance personalized deprescribing recommendations.

Abstract

Background:: Deprescribing has emerged as a critical intervention to address polypharmacy-related complications in older adults. This comprehensive review examines the current evidence base, implementation strategies, and future directions for deprescribing in geriatric populations. Objective:: To provide a comprehensive overview of deprescribing in older populations by examining its definition, evidence base, potential benefits and risks, implementation strategies, and emerging technologies, including applications of artificial intelligence. Methods:: A comprehensive narrative review was conducted using multiple databases, including Embase, Google Scholar, PubMed, and Scopus. Studies reporting deprescribing interventions in older adults, systematic reviews, meta-analyses, and articles addressing implementation barriers were included. References were hand-searched for additional relevant studies. Results:: Deprescribing interventions demonstrate significant benefits, including reduced adverse drug reactions (ADRs), decreased falls, improved quality of life, and reduced healthcare utilization. Evidence from multiple international studies shows success rates ranging from 67.4% to 96.9% across different clinical settings. However, potential negative effects include withdrawal symptoms, rebound effects, and disease relapse, occurring in approximately 26% of medication cessations. Key implementation facilitators include patient-centred approaches, multidisciplinary collaboration, and structured decisionmaking tools. Barriers include time constraints, clinician reluctance, and insufficient standardized protocols. Emerging artificial intelligence technologies show promise for personalizing deprescribing recommendations. Conclusions:: Successful deprescribing requires coordinated efforts integrating evidencebased protocols, patient-centred care, and multidisciplinary collaboration. Future research should focus on developing standardized methodologies, addressing implementation barriers, and exploring AI-assisted personalized approaches to optimize medication management in older adults.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alam et al. (2026) studied this question.

synapsesocial.com/papers/69b8f0fddeb47d591b8c5c0fhttps://doi.org/10.2174/0118756921397125251202105144
Ask AI
Helpful
Bookmark
Share
View Full Paper